Pricing Log in Create free account
Saturday 17 October 2026 Export PIII’s income statement to Excel — free account

P3 Health Partners Inc.

PIII Healthcare Medical Care Facilities

P3 Health Partners Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, down 2.76% from fiscal 2024. In the quarter to June 2026, revenue grew 8.60%, EPS grew 89.9%, free cash flow fell 272.2% and total debt fell 34.1%, each against the same quarter a year earlier.

4.27 0.13 +3.14%
Market cap
$30.1M
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
2/9
Altman Z
−1.27
Beneish M
n/a
Dividend safety
n/a
Overview Business Profile Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Total sells 0.82
Totals in millions of $.
Dec 25 Mar 26 Jun 26 Sep 26
Buy — — — — — — — — — — — —
Sell — — — — — — — — — 1 — —
Insider Ownership 42.89%

Capital & Financial Ratios $m

Market Cap 30.06
Revenue 1,502.84
Net Income (216.48)
Free Cash Flow (130.52)
Net Debt 98.08
Current Ratio 0.46 (below 1: weak)
Debt/Equity 1.64
P/E ratio 0.00
Fwd P/E —
P/S ratio 0.01
P/B ratio 0.00
Past 5Y EPS Growth —
This Y EPS Growth 83.94% (at or above 15%: strong)
Next Y EPS Growth (39.82%) (below 0%: weak)
Next Y revenue growth —
Next 5Y EPS Growth 51.17% (at or above 15%: strong)

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years
EV/Sales is 0.1×, against a ten-year median of 0.1×; over the ten years it ranged from 0.1× in 2024 to 22.9× in 2021.
P/S against its own 10 years 8.56%
10-year low 10-year high
EV/Sales against its own 10 years 2.91%
10-year low 10-year high

Dividends

Payout Ratio —
Annual Dividend Rate —
Annual Dividend Yield —
total individual payouts
2019 Powerpack
2018 Powerpack
2017 Powerpack
special payouts not included in total or ratios

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 41 44 26 22
Receivables 121 125 96 145
Inventory — — — —
Other — 0 — —
166 184 133 179
2023 2024 2025 Q'26
Payables 222 319 369 248
ST’ Debt — 75 45 22
Other 14 68 86 73
299 496 545 389

Compound Annual Growth %

10y 5y 3y
Sales — 24.33% 11.61%
Cash Flow — 0.00% 0.00%
Earnings — 0.00% 0.00%
Book Value — 0.00% 0.00%

Revenue $m

Mar Jun Sep Dec Year
’26 386 386 — — —
’25 373 356 345 385 1,459
’24 388 379 362 371 1,500
’23 302 329 288 347 1,266
’22 274 269 248 258 1,049
’21 151 145 156 185 637
’20 — — — — 491
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 (27) (62) — — —
’25 (33) (17) (15) (26) (91)
’24 (20) (10) (23) (57) (110)
’23 (24) (29) (8) (16) (76)
’22 (28) (45) (21) (32) (126)
’21 (13) (21) (6) (27) (66)
’20 — — — 0 (25)
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 (27) (62) — — —
’25 (33) (17) (16) (26) (91)
’24 (20) (10) (23) (57) (110)
’23 (24) (30) (8) (16) (78)
’22 (29) (46) (22) (32) (128)
’21 (14) (22) (7) (27) (70)
’20 — — — 0 (28)
Fiscal quarters ending in the months shown.

EPS $

Mar Jun Sep Dec Year
’26 0.32 (0.63) — — —
’25 (6.28) (6.23) (9.67) (23.02) (45.26)
’24 (8.00) (7.50) (15.50) (18.00) (54.00)
’23 (11.00) (4.50) (6.00) (11.00) (31.50)
’22 (73.10) (186.55) (13.50) (113.01k) (325.00)
’21 0.12 (0.26) — (3.74) (245.72)
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

2
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Trend 2026e 2027e 2028e
Price, $
Price, $ Low — — — — — 332.00 80.50 35.00 8.85 3.40

Analyst estimates 2026–2028

Powerpack
High — — — — — 836.50 424.50 278.00 72.00 14.50
People
People Employees — — — — 2 500 600 400 360 320
Revenue/emp, $m — — — 0.00 245.53 1.27 1.75 3.17 4.17 4.56
Income, $m
Income, $m Revenue — — — 145 491 637 1,049 1,266 1,500 1,459
Gross margin, % — — — 3.06 1.34 (3.45) (0.74) 2.50 (3.93) (4.12)
EBT — — — (42) (31) (204) (1,560) (184) (306) (321)
EBT margin, % — — — (28.85) (6.40) (32.06) (148.62) (14.51) (20.39) (22.00)
Net income — 0 — (42) (31) (204) (1,562) (186) (310) (323)
Depreciation — — — 0 1 11 1,403 87 86 98
Per share, $
Per share, $ Revenue — — — 0.00 12.28 766.43 1,261.99 667.29 516.69 446.34
Earnings — — — — (0.01) (314.91) (325.00) (30.50) (54.00) (45.26)
Cash flow — — — 0.00 (0.61) (79.93) (151.54) (40.06) (37.92) (27.91)
Capex — — — 0.00 (0.07) (4.10) (2.69) (0.96) 0.00 0.02
Free cash flow — — — 0.00 (0.69) (84.03) (154.22) (41.02) (37.92) (27.89)
Book value — — — 0.00 (3.26) 328.95 7.04 74.89 26.15 (47.49)
Shares, m — — — — 40 1 1 2 3 3
Valuation, ×
Valuation, × P/E — — — 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/S — — — 0.00 0.00 22.96 0.07 0.10 0.02 0.01
P/B — — — 61.39 61.39 53.50 13.21 0.87 0.43 0.00
EV/Sales — — — 0.00 0.00 22.87 0.15 0.15 0.12 0.18
EV/FCF — — — 0.00 0.00 (208.62) (1.21) (2.49) (1.54) (2.84)
Cash, $m
Cash, $m Operating cash flow — — — (28) (25) (66) (126) (76) (110) (91)
Capex — — — (1) (3) (3) (2) (2) — 0
Free cash flow — — — (30) (28) (70) (128) (78) (110) (91)
Balance, $m
Balance, $m Working capital — — — — 0 1 (141) (133) (312) (412)
Total debt — — — — 45 84 96 108 184 273
Net debt — — — — 6 (57) 78 67 140 248
Shareholders’ equity — — — — (130) 274 6 142 76 (155)
Returns, %
Returns, % ROA — — — 0.00 (59.02) (12.67) (16.67) (6.65) (16.52) (20.55)
ROIC — — — 0.00 0.00 (54.30) (1,163.92) (50.09) (92.83) (182.89)
ROE — — — 0.00 0.00 (218.34) (193.36) (78.08) (124.59) 373.15
Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

P3 Health Partners Inc. vs peers in Medical Care Facilities (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
AIRS AirSculpt Technologies, Inc. $102.0M — (loss-making) — (loss-making) −2.53% (below 0%: shrinking) n/m −131.07% (below 0%: shrinking) 61.38% (0.07%) Compare
JYNT The Joint Corp. $97.7M 26.0× 16.9× +14.41% (above 0%: growing) +400.00% (above 0%: growing) +432.31% (above 0%: growing) 83.68% (2.43%) Compare
PARK Park Dental Partners, Inc. $91.3M — (loss-making) — +12.15% (above 0%: growing) −65.84% (below 0%: shrinking) −34.78% (below 0%: shrinking) 14.37% 1.90% Compare
BTMD biote Corp. $39.9M 6.8× 11.0× −9.48% (below 0%: shrinking) n/m −174.16% (below 0%: shrinking) 65.38% (7.93%) Compare
PIII P3 Health Partners Inc. $30.1M — (loss-making) — +8.60% (above 0%: growing) n/m −272.24% (below 0%: shrinking) 22.26% 10.67%
CCEL Cryo-Cell International Inc. $29.4M — (loss-making) 43.8× −0.02% (below 0%: shrinking) +77.78% (above 0%: growing) −58.37% (below 0%: shrinking) 79.38% 28.04% Compare
DCGO DocGo Inc. $27.9M — (loss-making) — (loss-making) −8.70% (below 0%: shrinking) n/m −132.28% (below 0%: shrinking) 30.52% (24.41%) Compare
PAIYY Aesthetic Medical International Hldngs Group Ltd Sponsored ADR $15.9M — (loss-making) 8.3× +25,427.42% (above 0%: growing) n/m −206.36% (below 0%: shrinking) 42.70% (1.24%) Compare
CCM Concord Medical Services Holdings Limited $10.5M — (loss-making) — (loss-making) +37.65% (above 0%: growing) n/m −281.45% (below 0%: shrinking) (13.15%) 0.00% Compare
Median of peers $34.7M — 14.0× +6.06% +77.78% −131.67% 52.04% (0.65%)

All 55 Medical Care Facilities stocks →

P3 Health Partners Inc. (PIII) key facts

  • Concern: P3 Health Partners Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, down 2.76% from fiscal 2024.
  • P3 Health Partners Inc. (PIII) is a Medical Care Facilities company in the Healthcare sector, listed on Nasdaq.
  • As of October 16, 2026, PIII traded at $4.27, a market capitalization of $30.1 million.
  • Return on equity was 373.2% and debt-to-equity 1.64.
  • Its Piotroski F-score is 2 out of 9 and its Altman Z-score is −1.27 (distress zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.

P3 Health Partners Inc. (PIII) Latest News

No news at this impact. Lower the threshold for more.
stockrow.com/PIII · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com